Replies to post #64773 on Anavex Life Sciences Corp (AVXL)

[circa1762]

I get your point, but no BP is going to sit back and let another BP buy Anavex, potentially the future of CNS treatments, for a measly $8/share. Even if Anavex eventually proves not to be the future, until that is shown to be the case there is no way the company sells for peanuts. Competition would never allow it.